# FDA 483 - Stanford Blood Center - June 16, 2010

Source: https://www.globalkeysolutions.net/records/483/stanford-blood-center/9018f4b0-531f-4439-b5d6-3d0314a4d6ec

> FDA 483 for Stanford Blood Center on June 16, 2010. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Stanford Blood Center
- Inspection Date: 2010-06-16
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: The FDA inspected Stanford Medical School Blood Center in Palo Alto, CA, a blood bank. The inspection revealed significant issues related to the investigation of adverse reactions, specifically regarding a donor deferral. Additionally, the firm failed to submit multiple biological product deviation reports within the required timeframe.

## Related Documents

- [483 - 2024-11-26](https://www.globalkeysolutions.net/records/483/stanford-blood-center/3d98ce42-150d-4892-8aa9-1d84af2d5ac4)

## Related Officers

- [Government Employee](https://www.globalkeysolutions.net/people/aneel-k-sandhu/426b5d36-5c58-4f2e-ae8c-7076f8f52029)

Company: https://www.globalkeysolutions.net/companies/stanford-blood-center/63255433-311c-4503-ad0b-c6820849f4fe

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b